{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:53:48Z","timestamp":1781823228573,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,18]]},"DOI":"10.7759\/cureus.111113","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:28:02Z","timestamp":1781821682000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessing Pain Linked to High Metabolic and Glycolytic Shift in Neurofibromatosis Type 1 (NF1) Patients by Using a Bioenergetic Biomarker: A Pilot Study"],"prefix":"10.7759","author":[{"given":"Grover P","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Krager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayoung","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nukhet","family":"Aykin-Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Santos-Horta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02911-2","article-title":"Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis","volume":"18","author":"Lee TJ","year":"2023","unstructured":"Lee TJ, Chopra M, Kim RH, Parkin PC, Barnett-Tapia C. Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis. Orphanet J Rare Dis. 2023, 18:292. 10.1186\/s13023-023-02911-2","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius E","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, et al.. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021, 23:1506-13. 10.1038\/s41436-021-01170-5","journal-title":"Genet Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-04815-0","article-title":"The therapeutic potential of neurofibromin signaling pathways and binding partners","volume":"6","author":"B\u00e1ez-Flores J","year":"2023","unstructured":"B\u00e1ez-Flores J, Rodr\u00edguez-Mart\u00edn M, Lacal J. The therapeutic potential of neurofibromin signaling pathways and binding partners. Commun Biol. 2023, 6:436. 10.1038\/s42003-023-04815-0","journal-title":"Commun Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115850","article-title":"Current understanding of neurofibromatosis type 1, 2, and schwannomatosis","volume":"22","author":"Tamura R","year":"2021","unstructured":"Tamura R. Current understanding of neurofibromatosis type 1, 2, and schwannomatosis. Int J Mol Sci. 2021, 22:16-8. 10.3390\/ijms22115850","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(01)00245-8","article-title":"NF1 tumor suppressor gene function: narrowing the GAP","volume":"104","author":"Cichowski K","year":"2001","unstructured":"Cichowski K, Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell. 2001, 104:593-604. 10.1016\/s0092-8674(01)00245-8","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner N","year":"2015","unstructured":"Ratner N, Miller SJ. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer. 2015, 15:290-301. 10.1038\/nrc3911","journal-title":"Nat Rev Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/embor.2010.160","article-title":"MAPK signalling in cellular metabolism: stress or wellness?","volume":"11","author":"Gehart H","year":"2010","unstructured":"Gehart H, Kumpf S, Ittner A, Ricci R. MAPK signalling in cellular metabolism: stress or wellness?. EMBO Rep. 2010, 11:834-40. 10.1038\/embor.2010.160","journal-title":"EMBO Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38058","article-title":"Analysis of copy number variants in 11 pairs of monozygotic twins with neurofibromatosis type 1","volume":"173","author":"Sites ER","year":"2017","unstructured":"Sites ER, Smolarek TA, Martin LJ, et al.. Analysis of copy number variants in 11 pairs of monozygotic twins with neurofibromatosis type 1. Am J Med Genet A. 2017, 173:647-53. 10.1002\/ajmg.a.38058","journal-title":"Am J Med Genet A"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1375\/twin.13.6.582","article-title":"Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5' untranslated region, exon and intron 1","volume":"13","author":"Harder A","year":"2010","unstructured":"Harder A, Titze S, Herbst L, et al.. Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5' untranslated region, exon and intron 1. Twin Res Hum Genet. 2010, 13:582-94. 10.1375\/twin.13.6.582","journal-title":"Twin Res Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2019.05.006","article-title":"Increased resting metabolism in neurofibromatosis type 1","volume":"32","author":"Souza ML","year":"2019","unstructured":"Souza ML, Jansen AK, Rodrigues LO, et al.. Increased resting metabolism in neurofibromatosis type 1. Clin Nutr ESPEN. 2019, 32:44-9. 10.1016\/j.clnesp.2019.05.006","journal-title":"Clin Nutr ESPEN"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24505-x","article-title":"Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila","volume":"12","author":"Botero V","year":"2021","unstructured":"Botero V, Stanhope BA, Brown EB, et al.. Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila. Nat Commun. 2021, 12:4285. 10.1038\/s41467-021-24505-x","journal-title":"Nat Commun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/ng2004","article-title":"Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster","volume":"39","author":"Tong JJ","year":"2007","unstructured":"Tong JJ, Schriner SE, McCleary D, Day BJ, Wallace DC. Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster. Nat Genet. 2007, 39:476-85. 10.1038\/ng2004","journal-title":"Nat Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.12.056","article-title":"Absence of neurofibromin induces an oncogenic metabolic switch via mitochondrial ERK-mediated phosphorylation of the chaperone TRAP1","volume":"18","author":"Masgras I","year":"2017","unstructured":"Masgras I, Ciscato F, Brunati AM, et al.. Absence of neurofibromin induces an oncogenic metabolic switch via mitochondrial ERK-mediated phosphorylation of the chaperone TRAP1. Cell Rep. 2017, 18:659-72. 10.1016\/j.celrep.2016.12.056","journal-title":"Cell Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable plexiform neurofibromas","volume":"382","author":"Gross AM","year":"2020","unstructured":"Gross AM, Wolters PL, Dombi E, et al.. Selumetinib in children with inoperable plexiform neurofibromas. N Engl J Med. 2020, 382:1430-42. 10.1056\/NEJMoa1912735","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00986-9","article-title":"Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study","volume":"405","author":"Chen AP","year":"2025","unstructured":"Chen AP, Coyne GO, Wolters PL, et al.. Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study. Lancet. 2025, 405:2217-30. 10.1016\/S0140-6736(25)00986-9","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.01034","article-title":"ReNeu: a pivotal, phase IIb trial of mirdametinib in adults and children with symptomatic neurofibromatosis type 1-associated plexiform neurofibroma","volume":"43","author":"Moertel CL","year":"2025","unstructured":"Moertel CL, Hirbe AC, Shuhaiber HH, et al.. ReNeu: a pivotal, phase IIb trial of mirdametinib in adults and children with symptomatic neurofibromatosis type 1-associated plexiform neurofibroma. J Clin Oncol. 2025, 43:716-29. 10.1200\/JCO.24.01034","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000711","article-title":"MEK inhibitors in RASopathies","volume":"33","author":"Bergqvist C","year":"2021","unstructured":"Bergqvist C, Wolkenstein P. MEK inhibitors in RASopathies. Curr Opin Oncol. 2021, 33:110-9. 10.1097\/CCO.0000000000000711","journal-title":"Curr Opin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.430082","article-title":"Acute mitochondrial inhibition by mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase (MEK) 1\/2 inhibitors regulates proliferation","volume":"288","author":"Ripple MO","year":"2013","unstructured":"Ripple MO, Kim N, Springett R. Acute mitochondrial inhibition by mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase (MEK) 1\/2 inhibitors regulates proliferation. J Biol Chem. 2013, 288:2933-40. 10.1074\/jbc.M112.430082","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.17179\/excli2022-4935","article-title":"Pivotal role of vitamin D in mitochondrial health, cardiac function, and human reproduction","volume":"21","author":"Matta Reddy A","year":"2022","unstructured":"Matta Reddy A, Iqbal M, Chopra H, et al.. Pivotal role of vitamin D in mitochondrial health, cardiac function, and human reproduction. EXCLI J. 2022, 21:967-90. 10.17179\/excli2022-4935","journal-title":"EXCLI J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"17","author":"Parikh S","year":"2015","unstructured":"Parikh S, Goldstein A, Koenig MK, et al.. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015, 17:689-701. 10.1038\/gim.2014.177","journal-title":"Genet Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/antiox7090121","article-title":"PCB11 metabolite, 3,3'-dichlorobiphenyl-4-ol, exposure alters the expression of genes governing fatty acid metabolism in the absence of functional sirtuin 3: examining the contribution of MnSOD","volume":"7","author":"Alam S","year":"2018","unstructured":"Alam S, Carter GS, Krager KJ, Li X, Lehmler HJ, Aykin-Burns N. PCB11 metabolite, 3,3'-dichlorobiphenyl-4-ol, exposure alters the expression of genes governing fatty acid metabolism in the absence of functional sirtuin 3: examining the contribution of MnSOD. Antioxidants (Basel). 2018, 7:23-5. 10.3390\/antiox7090121","journal-title":"Antioxidants (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138815","article-title":"Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence","volume":"5","author":"Kim HN","year":"2020","unstructured":"Kim HN, Xiong J, MacLeod RS, et al.. Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence. JCI Insight. 2020, 5:23-5. 10.1172\/jci.insight.138815","journal-title":"JCI Insight"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.000834","article-title":"Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo","volume":"293","author":"Wang L","year":"2018","unstructured":"Wang L, Fang B, Fujiwara T, et al.. Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo. J Biol Chem. 2018, 293:9248-64. 10.1074\/jbc.RA117.000834","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12304","article-title":"Increased mitochondrial proton leak and glycolysis in peripheral blood mononuclear cells in type-1-diabetes","volume":"8","author":"Lopes de Melo JM","year":"2022","unstructured":"Lopes de Melo JM, Laursen JC, S\u00f8ndergaard-Heinrich N, et al.. Increased mitochondrial proton leak and glycolysis in peripheral blood mononuclear cells in type-1-diabetes. Heliyon. 2022, 8:e12304. 10.1016\/j.heliyon.2022.e12304","journal-title":"Heliyon"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.629239","article-title":"Metabolic changes in peripheral blood mononuclear cells isolated from patients with end stage renal disease","volume":"12","author":"Altintas MM","year":"2021","unstructured":"Altintas MM, DiBartolo S, Tadros L, Samelko B, Wasse H. Metabolic changes in peripheral blood mononuclear cells isolated from patients with end stage renal disease. Front Endocrinol (Lausanne). 2021, 12:629239. 10.3389\/fendo.2021.629239","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81217-4","article-title":"Novel standardized method for extracellular flux analysis of oxidative and glycolytic metabolism in peripheral blood mononuclear cells","volume":"11","author":"Janssen JJ","year":"2021","unstructured":"Janssen JJ, Lagerwaard B, Bunschoten A, Savelkoul HF, van Neerven RJ, Keijer J, de Boer VC. Novel standardized method for extracellular flux analysis of oxidative and glycolytic metabolism in peripheral blood mononuclear cells. Sci Rep. 2021, 11:1662. 10.1038\/s41598-021-81217-4","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","volume":"33","author":"Morrissey SM","year":"2021","unstructured":"Morrissey SM, Zhang F, Ding C, et al.. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 2021, 33:2040-2058.e10. 10.1016\/j.cmet.2021.09.002","journal-title":"Cell Metab"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2017.04.003","article-title":"Dysfunctional T cell metabolism in the tumor microenvironment","volume":"35","author":"Beckermann KE","year":"2017","unstructured":"Beckermann KE, Dudzinski SO, Rathmell JC. Dysfunctional T cell metabolism in the tumor microenvironment. Cytokine Growth Factor Rev. 2017, 35:7-14. 10.1016\/j.cytogfr.2017.04.003","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X14521315","article-title":"Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus","volume":"19","author":"Hartman ML","year":"2014","unstructured":"Hartman ML, Shirihai OS, Holbrook M, et al.. Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus. Vasc Med. 2014, 19:67-74. 10.1177\/1358863X14521315","journal-title":"Vasc Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5923938","article-title":"Mitochondrial alterations in peripheral mononuclear blood cells from Alzheimer's disease and mild cognitive impairment patients","volume":"2016","author":"Delbarba A","year":"2016","unstructured":"Delbarba A, Abate G, Prandelli C, et al.. Mitochondrial alterations in peripheral mononuclear blood cells from Alzheimer's disease and mild cognitive impairment patients. Oxid Med Cell Longev. 2016, 2016:5923938. 10.1155\/2016\/5923938","journal-title":"Oxid Med Cell Longev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020311","article-title":"Peripheral blood mononuclear cells and platelets mitochondrial dysfunction, oxidative stress, and circulating mtDNA in cardiovascular diseases","volume":"9","author":"Alfatni A","year":"2020","unstructured":"Alfatni A, Riou M, Charles AL, et al.. Peripheral blood mononuclear cells and platelets mitochondrial dysfunction, oxidative stress, and circulating mtDNA in cardiovascular diseases. J Clin Med. 2020, 9:23-5. 10.3390\/jcm9020311","journal-title":"J Clin Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping NE","year":"2021","unstructured":"Scharping NE, Rivadeneira DB, Menk AV, et al.. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat Immunol. 2021, 22:205-15. 10.1038\/s41590-020-00834-9","journal-title":"Nat Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101140","article-title":"From OCR and ECAR to energy: perspectives on the design and interpretation of bioenergetics studies","volume":"297","author":"Schmidt CA","year":"2021","unstructured":"Schmidt CA, Fisher-Wellman KH, Neufer PD. From OCR and ECAR to energy: perspectives on the design and interpretation of bioenergetics studies. J Biol Chem. 2021, 297:101140. 10.1016\/j.jbc.2021.101140","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2018.10.006","article-title":"Phenotypic expression of a spectrum of neurofibromatosis type 1 (NF1) mutations identified through NGS and MLPA","volume":"395","author":"Tsipi M","year":"2018","unstructured":"Tsipi M, Poulou M, Fylaktou I, et al.. Phenotypic expression of a spectrum of neurofibromatosis type 1 (NF1) mutations identified through NGS and MLPA. J Neurol Sci. 2018, 395:95-105. 10.1016\/j.jns.2018.10.006","journal-title":"J Neurol Sci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-00991-4","article-title":"Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD(+) and SIRT3","volume":"29","author":"Masgras I","year":"2022","unstructured":"Masgras I, Cannino G, Ciscato F, et al.. Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD(+) and SIRT3. Cell Death Differ. 2022, 29:1996-2008. 10.1038\/s41418-022-00991-4","journal-title":"Cell Death Differ"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101876","article-title":"NF1 deficiency drives metabolic reprogramming in ER+ breast cancer","volume":"80","author":"House RR","year":"2024","unstructured":"House RR, Tovar EA, Redlon LN, et al.. NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. Mol Metab. 2024, 80:101876. 10.1016\/j.molmet.2024.101876","journal-title":"Mol Metab"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010061","article-title":"The lipid asset is unbalanced in peripheral nerve sheath tumors","volume":"23","author":"Vetrano IG","year":"2021","unstructured":"Vetrano IG, Dei Cas M, Nazzi V, et al.. The lipid asset is unbalanced in peripheral nerve sheath tumors. Int J Mol Sci. 2021, 23:14-6. 10.3390\/ijms23010061","journal-title":"Int J Mol Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg O","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956, 123:309-14. 10.1126\/science.123.3191.309","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1158\/jcr.1925.148","article-title":"The metabolism of carcinoma cells","volume":"9","author":"Warburg O","year":"1925","unstructured":"Warburg O. The metabolism of carcinoma cells. J Cancer Res. 1925, 9:148-63.","journal-title":"J Cancer Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s12990-015-0057-7","article-title":"Mitochondrial and bioenergetic dysfunction in trauma-induced painful peripheral neuropathy","volume":"11","author":"Lim TK","year":"2015","unstructured":"Lim TK, Rone MB, Lee S, Antel JP, Zhang J. Mitochondrial and bioenergetic dysfunction in trauma-induced painful peripheral neuropathy. Mol Pain. 2015, 11:58. 10.1186\/s12990-015-0057-7","journal-title":"Mol Pain"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000002252","article-title":"Comparison of oxygen consumption rates of nondegenerate and degenerate human intervertebral disc cells","volume":"43","author":"Cisewski SE","year":"2018","unstructured":"Cisewski SE, Wu Y, Damon BJ, Sachs BL, Kern MJ, Yao H. Comparison of oxygen consumption rates of nondegenerate and degenerate human intervertebral disc cells. Spine (Phila Pa 1976). 2018, 43:E60-7. 10.1097\/BRS.0000000000002252","journal-title":"Spine (Phila Pa 1976)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/435521-assessing-pain-linked-to-high-metabolic-and-glycolytic-shift-in-neurofibromatosis-type-1-nf1-patients-by-using-a-bioenergetic-biomarker-a-pilot-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:28:03Z","timestamp":1781821683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/435521-assessing-pain-linked-to-high-metabolic-and-glycolytic-shift-in-neurofibromatosis-type-1-nf1-patients-by-using-a-bioenergetic-biomarker-a-pilot-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.111113","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}